Browsing: Uncategorized

It would be a stretch to say the J.P. Morgan Healthcare Conference is an in vitro diagnostics meeting. Healthcare IT…

Lab-developed tests, lab consolidation and infectious disease threats dominated the news relative to in vitro diagnostic (IVD) companies in 2024,…

A TALE OF 137 TERABYTES: WEBINAR TALKS ABOUT DATA OPPORTUNITY IN IVD THANKS TO WEARABLES AND AIImagine 60 laptops. Now…

On December 4th, Eye On IVD consulted three IVD industry experts to talk about less than notable trends. We have…

According to Siemens, nearly 49% of patients with elevated troponin I levels may experience a major adverse cardiac event or…

Billions of dollars will be earned by companies who can develop tests that improve the diagnosis of viral, bacterial, fungal…

“Arbitrary and capricious” is what the College of American Pathologists (CAP) has called the process of deciding to regulate lab-developed…

Thanks to those who joined our EYE ON IVD State of the IVD Industry Webinar 2024 last week – with…

EYE ON IVD held its first “State of the IVD Industry 2024” webinar yesterday by introducing key topics like the…

The Association for Diagnostic and Laboratory Medicine (ADLM) conducted a survey of clinical labs and the results are troubling. If…